Home / France / Erytech Pharma
Erytech Pharma
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
68 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
March 31, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on Erytech Pharma by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 8, 2015 | GSA Capital Partners L.L.P. | 1.51% | August 8, 2016 |
| November 23, 2015 | GSA Capital Partners L.L.P. | 1.70% | August 8, 2016 |
| October 26, 2015 | GSA Capital Partners L.L.P. | 1.60% | August 8, 2016 |
| October 23, 2015 | GSA Capital Partners L.L.P. | 1.59% | August 8, 2016 |
| October 22, 2015 | GSA Capital Partners L.L.P. | 1.60% | August 8, 2016 |
| October 12, 2015 | GSA Capital Partners L.L.P. | 1.50% | August 8, 2016 |
| September 24, 2015 | GSA Capital Partners L.L.P. | 1.40% | August 8, 2016 |
| August 21, 2015 | GSA Capital Partners L.L.P. | 1.30% | August 8, 2016 |
| July 27, 2015 | GSA Capital Partners L.L.P. | 1.20% | August 8, 2016 |
| June 22, 2015 | GSA Capital Partners L.L.P. | 1.10% | August 8, 2016 |
| June 18, 2015 | GSA Capital Partners L.L.P. | 1.09% | August 8, 2016 |
| June 16, 2015 | GSA Capital Partners L.L.P. | 1.10% | August 8, 2016 |
| May 26, 2015 | GSA Capital Partners L.L.P. | 1.00% | August 8, 2016 |
| May 19, 2015 | GSA Capital Partners L.L.P. | 0.92% | August 8, 2016 |
| May 11, 2015 | GSA Capital Partners L.L.P. | 0.81% | August 8, 2016 |
| April 27, 2015 | GSA Capital Partners L.L.P. | 0.70% | August 8, 2016 |
| April 7, 2015 | GSA Capital Partners L.L.P. | 0.61% | August 8, 2016 |
| March 31, 2015 | GSA Capital Partners L.L.P. | 0.54% | August 8, 2016 |
Download 68 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.56% of the capital sold short
- Valeo 10.69% of the capital sold short
- Renault 9.59% of the capital sold short
- Teleperformance 8.38% of the capital sold short
- Viridien 7.04% of the capital sold short
- FDJ United 6.39% of the capital sold short
- Abivax 5.00% of the capital sold short
- Worldline 4.75% of the capital sold short
- Remy Cointreau 4.55% of the capital sold short
- Alstom 4.52% of the capital sold short
- Vusiongroup 3.99% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Erytech Pharma, source AMF, data as at December 16, 2021, https://www.quivad.com/action/erytech-pharma?page=2